Tenon Regains Nasdaq Compliance After Reverse Split, Boosting Short-Term Liquidity
Aug 24, 2026, 1:05 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Regained listing compliance reduces delisting risk and can improve liquidity and investor confidence; typical near-term rebound expectations after a compliance-positive event and a successful reverse split.
AI summary
What happened, with direct paths to the underlying reporting
Tenon Medical disclosed Nasdaq notified it regained compliance with the $1 bid price rule after completing a 1-for-35 reverse split. The stock traded above $1 for 10 consecutive days, alleviating delisting risk and restoring normal market access on the Nasdaq Capital Market. The update provides near-term liquidity relief, though long-term growth hinges on SI Joint device adoption.
Nasdaq confirms TNON regained minimum bid price after reverse split.
Closing bid price above $1 for 10 straight trading days (Aug 10–21).
1-for-35 reverse stock split completed Aug 10, 2026.
Acquisitions of SiVantage and SIMPL Medical in Aug 2025 broaden SI Joint portfolio.
TNON remains listed on Nasdaq Capital Market under ticker TNON.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event